跳至主要内容
临床试验/IRCT20220130053890N1
IRCT20220130053890N1招募中3 期

Comparing the efficacy of inhaled versus infused milrinone in management of persistent pulmonary hypertension(PPHN) in infants

Iran University of Medical Sciences0 个研究点目标入组 32 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 28 days(—)
性别
All

入选标准

  • Infants 1 to 28 days with a diagnosis of persistent pulmonary hypertension (diagnosed on Basis of echocardiographic findings) and hospitalization in the NICU.
  • Indicated for receiving treatment based on the diagnosis of the treating physician.
  • Existence of informed consent of parents to enter the study.

排除标准

  • Neonates with congenital heart disorders, diaphragmatic hernias, pulmonary abnormalities.
  • infants are candidates for major surgery to eliminate abnormality.

研究者

相似试验